Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 3 1Phase 1 1

Status

Recruiting 3Unknown 1Completed 1

Sponsor Class

OTHER 117INDUSTRY 5NETWORK 2FED 2

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Breast 3Thoracic 1Other hematologic neoplasm 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 2Neoplasm Metastasis 2Leukemia, Myeloid, Acute 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 1019Carboplatin 959Paclitaxel 932Gemcitabine 793Cisplatin 748Docetaxel 682Bevacizumab 610Pemetrexed 502Nivolumab 486Cyclophosphamide 466Capecitabine 461Fluorouracil 417Dexamethasone 402Rituximab 372Oxaliplatin 347Injections 342atezolizumab 297Trastuzumab 297Leucovorin 286Cetuximab 282Irinotecan 266130-nm albumin-bound paclitaxel 252Prednisone 244Doxorubicin 240Ipilimumab 226Lenalidomide 220Fulvestrant 217fludarabine 214durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Palliative Care × Clear all
NCT07510802 2026-04-06

Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

Beijing Biotech

Phase 1/2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT07486089 2026-03-20

DUAL-NK-BC

Beijing Biotech

Phase 1/2 Recruiting
60 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT07467863 2026-03-12

DUO-NK-NSCLC

Beijing Biotech

Phase 1/2 Recruiting
48 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00260832 2019-09-11

Trial of Decitabine in Patients With Acute Myeloid Leukemia

Eisai Inc.

Phase 3 Completed
485 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01016574 2011-08-03

IN902

Azimuth Therapy Ltd.

Phase 1 Unknown
15 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡